These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 28562278)

  • 21. Opioid agonist treatment for people who are dependent on pharmaceutical opioids.
    Nielsen S; Tse WC; Larance B
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD011117. PubMed ID: 36063082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methadone exposure during lactation.
    Glatstein MM; Garcia-Bournissen F; Finkelstein Y; Koren G
    Can Fam Physician; 2008 Dec; 54(12):1689-90. PubMed ID: 19074706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opioid analgesic exposure during the first trimester of pregnancy and the risk of major congenital malformations in infants: a systematic review and meta-analysis
    Varney B; Brett J; Zoega H; Gillies MB; Powell M; Bateman BT; Shand AW; Pearson SA; Havard A
    Anaesthesia; 2024 Sep; 79(9):967-977. PubMed ID: 38715235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Buprenorphine versus methadone in pregnant opioid-dependent women: a prospective multicenter study.
    Lacroix I; Berrebi A; Garipuy D; Schmitt L; Hammou Y; Chaumerliac C; Lapeyre-Mestre M; Montastruc JL; Damase-Michel C
    Eur J Clin Pharmacol; 2011 Oct; 67(10):1053-9. PubMed ID: 21538146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maternal Complications and Prescription Opioid Exposure During Pregnancy: Using Marginal Structural Models.
    Wen X; Wang S; Lewkowitz AK; Ward KE; Brousseau EC; Meador KJ
    Drug Saf; 2021 Dec; 44(12):1297-1309. PubMed ID: 34609720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication.
    Kaltenbach K; Holbrook AM; Coyle MG; Heil SH; Salisbury AL; Stine SM; Martin PR; Jones HE
    Addiction; 2012 Nov; 107 Suppl 1(0 1):45-52. PubMed ID: 23106926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opioid Utilization by Pregnant Women with Sickle Cell Disease and the Risk of Neonatal Abstinence Syndrome.
    Nnoli A; Seligman NS; Dysart K; Baxter JK; Ballas SK
    J Natl Med Assoc; 2018 Apr; 110(2):163-168. PubMed ID: 29580450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Buprenorphine-naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder.
    Kanervo MM; Tupola SJ; Nikkola EM; Rantakari KM; Kahila HK
    Acta Obstet Gynecol Scand; 2023 Mar; 102(3):313-322. PubMed ID: 36562462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative Safety Analysis of Opioid Agonist Treatment in Pregnant Women with Opioid Use Disorder: A Population-Based Study.
    Wang S; Meador KJ; Pawasauskas J; Lewkowitz AK; Ward KE; Brothers TN; Hartzema A; Quilliam BJ; Wen X
    Drug Saf; 2023 Mar; 46(3):257-271. PubMed ID: 36642778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of timing of methadone initiation on perinatal outcomes following delivery among pregnant women on methadone maintenance therapy in Ontario.
    Guan Q; Sproule BA; Vigod SN; Cadarette SM; Greaves S; Martins D; Gomes T
    Addiction; 2019 Feb; 114(2):268-277. PubMed ID: 30276907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes.
    Veroniki AA; Cogo E; Rios P; Straus SE; Finkelstein Y; Kealey R; Reynen E; Soobiah C; Thavorn K; Hutton B; Hemmelgarn BR; Yazdi F; D'Souza J; MacDonald H; Tricco AC
    BMC Med; 2017 May; 15(1):95. PubMed ID: 28472982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydroxychloroquine early in pregnancy and risk of birth defects.
    Huybrechts KF; Bateman BT; Zhu Y; Straub L; Mogun H; Kim SC; Desai RJ; Hernandez-Diaz S
    Am J Obstet Gynecol; 2021 Mar; 224(3):290.e1-290.e22. PubMed ID: 32961123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed Neonates.
    Kelty E; Hulse G
    Drugs; 2017 Jul; 77(11):1211-1219. PubMed ID: 28536981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripartum Anesthetic Management of the Opioid-tolerant or Buprenorphine/Suboxone-dependent Patient.
    Pan A; Zakowski M
    Clin Obstet Gynecol; 2017 Jun; 60(2):447-458. PubMed ID: 28426507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of neonatal outcomes in pregnant women undergoing medication-assisted treatment of opioid use disorder with methadone or buprenorphine/naloxone.
    Petrich M; Battin M; Walker E; Brown M; Abdelwahab M; Ma'ayeh M; Rood KM
    J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10481-10486. PubMed ID: 36202398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Buprenorphine and methadone for opioid addiction during pregnancy.
    Mozurkewich EL; Rayburn WF
    Obstet Gynecol Clin North Am; 2014 Jun; 41(2):241-53. PubMed ID: 24845488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hospitalization of children after prenatal exposure to opioid maintenance therapy during pregnancy: a national registry study from the Czech Republic.
    Skurtveit S; Nechanská B; Handal M; Mahic M; Mravčík V; Gabrhelík R
    Addiction; 2019 Jul; 114(7):1225-1235. PubMed ID: 30725515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pregnancy outcome following opioid exposure: A cohort study.
    Fishman B; Daniel S; Koren G; Lunenfeld E; Levy A
    PLoS One; 2019; 14(7):e0219061. PubMed ID: 31260464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Supervised dosing with a long-acting opioid medication in the management of opioid dependence.
    Saulle R; Vecchi S; Gowing L
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011983. PubMed ID: 28447766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized controlled trials in pregnancy: scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra-individual comparison.
    Unger A; Jagsch R; Jones H; Arria A; Leitich H; Rohrmeister K; Aschauer C; Winklbaur B; Bäwert A; Fischer G
    Addiction; 2011 Jul; 106(7):1355-62. PubMed ID: 21438938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.